January 25, 2018
Regeneron revealed that Dupixent generated sales of $120M within the first nine months of launch. Researchers have identified a possible treatment for moderate-to-severe atopic dermatitis: IL-22 blockade. Product launches or updates from Revision Skincare, Alastin Skincare, Ortho Dermatologics, and Intraderm. Adam Friedman, MD has been awarded the Innovations in Residency Training Award at the Orlando Dermatology Aesthetic & Clinical Conference (ODAC). And introducing DermWire News for smart speaker: Alexa, play Dermatology News.